1509Background: We initiated the Chicago Multiethnic Prevention and Surveillance Study (COMPASS) in 2013. Here, we present screening rates for key cancers with known disparities in risk/and or outcomes in Chicago,… Click to show full abstract
1509Background: We initiated the Chicago Multiethnic Prevention and Surveillance Study (COMPASS) in 2013. Here, we present screening rates for key cancers with known disparities in risk/and or outcomes in Chicago, considering the effect health care access and race/ethnicity, and we compare the findings in COMPASS to rates reported by the CDC. Methods: COMPASS participant responses to a health interview were analyzed. The analysis of colorectal cancer screening (CRCS) was limited to persons 50-75, mammography screening (MS) was restricted to women ages 50-74, and cervical screening (CS) by pap smear testing was restricted to women ages 21-65. Frequency statistics and linear regression models were run to evaluate associations. Results: A total of 2,967 COMPASS participants were included in the analysis from 18 communities. We found ever CRCS rates in Chicago are lower than the national average (52.3% vs. 58.6%; p < .01) and that CRCS is lower in blacks (50.3%) and Hispanics (52.1%) compared to whites (65.8%...
               
Click one of the above tabs to view related content.